cecropin a

Cecropin A is a naturally occurring, linear, cationic, 37-residue antimicrobial peptide.

Cecropin A TFA is an antimicrobial polypeptide isolated from Hyalaphora cecropia pupae with anti-inflammatory, anti-bacterial, and anti-cancer activity.

Cecropin A TFA, a linear 37-residue antimicrobial polypeptide derived from Hyalaphora cecropia pupae, exhibits anti-bacterial, anti-inflammatory [1], and anti-cancer activities [2].

Cecropin A (1-7)-Melittin A (2-9) is an antimicrobial peptide with broad-spectrum activity against both Gram-positive and Gram-negative aerobic bacteria, as well as antimalarial properties, without the adverse hemolytic effects commonly associated with bee venom peptides [1].

Cecropin D, an antimicrobial peptide, exhibits a minimum inhibitory concentration (MIC) of 4.55 μg/mL and demonstrates efficacy against both Gram-negative and Gram-positive bacteria. Additionally, it possesses antiviral, antifungal, antitumor, and immunomodulatory properties [1] [2].

Cecropin B is a small antibacterial peptide from the giant silkmoth, Hyalophora cecropia.

Cecropin P1, porcine, is an antibacterial peptide first identified in moths (Hyalophora cecropia) and subsequently found in pig intestines.

Cecropin P1 (porcine acetate) is an antibacterial peptide present in Hyalophora cecropia and the pig intestine.

Cecropin B acetate induces NF-κB activation and suppresses CYP3A29 by disrupting the association of the PXR/retinoid X receptor alpha (RXR-α) complex with DNA sequences. Cecropin B acetate exhibits strong antimicrobial activity.

KN-17, a modified derivative based on the cecropin B structure, effectively disrupts bacterial growth and induces the migration of human bone marrow stromal cells (hBMSCs). This compound significantly stimulates angiogenesis both in vitro and in vivo.

Peceleganan (PL-5), a synthetic hybrid peptide, combines cecropin A (1-10) and melittin B (3-18) sequences to form a (10+16)-peptide analogue with antimicrobial properties. This compound effectively inhibits wound infections [1].

Peceleganan acetate (PL-5), a synthetic hybrid analogue combining segments of cecropin A (1-10) and melittin B (3-18) to form a (10+16)-peptide, demonstrates antimicrobial properties. It is specifically effective in inhibiting wound infections [1].

D2A21 is a cecropin peptide with a minimum inhibitory concentration of 21.69 μg/mL against Chlamydia trachomatis.